High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation

High-risk human papillomavirus infection may develop into a persistent infection that is highly related to the progression of various cancers, including cervical cancer and head and neck squamous cell carcinomas. The most common high-risk subtypes are HPV16 and HPV18. The oncogenic viral proteins ex...

Full description

Bibliographic Details
Main Authors: Yunji Zheng, Xue Li, Yisheng Jiao, Chengjun Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.929666/full
_version_ 1818157222787547136
author Yunji Zheng
Xue Li
Yisheng Jiao
Chengjun Wu
author_facet Yunji Zheng
Xue Li
Yisheng Jiao
Chengjun Wu
author_sort Yunji Zheng
collection DOAJ
description High-risk human papillomavirus infection may develop into a persistent infection that is highly related to the progression of various cancers, including cervical cancer and head and neck squamous cell carcinomas. The most common high-risk subtypes are HPV16 and HPV18. The oncogenic viral proteins expressed by high-risk HPVs E6/E7 are tightly involved in cell proliferation, differentiation, and cancerous transformation since E6/E7 mRNAs are derived from the same pre-mRNA. Hence, the alternative splicing in the E6/E7-coding region affects the balance of the E6/E7 expression level. Interrupting the balance of E6 and E7 levels results in cell apoptosis. Therefore, it is crucial to understand the regulation of E6/E7 splice site selection and the interaction of splicing enhancers and silencers with cellular splicing factors. In this review, we concluded the relationship of different E6/E7 transcripts with cancer progression, the known splicing sites, and the identified cis-regulatory elements within high-risk HPV E6/E7-coding region. Finally, we also reviewed the role of various splicing factors in the regulation of high-risk HPV oncogenic E6/E7 mRNA splicing.
first_indexed 2024-12-11T15:10:46Z
format Article
id doaj.art-fed2a5a3fa6c481c88a4ddb62e05b708
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-12-11T15:10:46Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-fed2a5a3fa6c481c88a4ddb62e05b7082022-12-22T01:00:46ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882022-06-011210.3389/fcimb.2022.929666929666High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing RegulationYunji Zheng0Xue Li1Yisheng Jiao2Chengjun Wu3School of Pharmacy, Binzhou Medical University, Yantai, ChinaSchool of Pharmacy, Binzhou Medical University, Yantai, ChinaSchool of Biomedical Engineering, Dalian University of Technology, Dalian, ChinaSchool of Biomedical Engineering, Dalian University of Technology, Dalian, ChinaHigh-risk human papillomavirus infection may develop into a persistent infection that is highly related to the progression of various cancers, including cervical cancer and head and neck squamous cell carcinomas. The most common high-risk subtypes are HPV16 and HPV18. The oncogenic viral proteins expressed by high-risk HPVs E6/E7 are tightly involved in cell proliferation, differentiation, and cancerous transformation since E6/E7 mRNAs are derived from the same pre-mRNA. Hence, the alternative splicing in the E6/E7-coding region affects the balance of the E6/E7 expression level. Interrupting the balance of E6 and E7 levels results in cell apoptosis. Therefore, it is crucial to understand the regulation of E6/E7 splice site selection and the interaction of splicing enhancers and silencers with cellular splicing factors. In this review, we concluded the relationship of different E6/E7 transcripts with cancer progression, the known splicing sites, and the identified cis-regulatory elements within high-risk HPV E6/E7-coding region. Finally, we also reviewed the role of various splicing factors in the regulation of high-risk HPV oncogenic E6/E7 mRNA splicing.https://www.frontiersin.org/articles/10.3389/fcimb.2022.929666/fullhigh-risk HPVscervical cancerHNSCCE6/E7splicingsplicing factors
spellingShingle Yunji Zheng
Xue Li
Yisheng Jiao
Chengjun Wu
High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation
Frontiers in Cellular and Infection Microbiology
high-risk HPVs
cervical cancer
HNSCC
E6/E7
splicing
splicing factors
title High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation
title_full High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation
title_fullStr High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation
title_full_unstemmed High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation
title_short High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation
title_sort high risk human papillomavirus oncogenic e6 e7 mrnas splicing regulation
topic high-risk HPVs
cervical cancer
HNSCC
E6/E7
splicing
splicing factors
url https://www.frontiersin.org/articles/10.3389/fcimb.2022.929666/full
work_keys_str_mv AT yunjizheng highriskhumanpapillomavirusoncogenice6e7mrnassplicingregulation
AT xueli highriskhumanpapillomavirusoncogenice6e7mrnassplicingregulation
AT yishengjiao highriskhumanpapillomavirusoncogenice6e7mrnassplicingregulation
AT chengjunwu highriskhumanpapillomavirusoncogenice6e7mrnassplicingregulation